Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | CA9 | Q16790 | 3/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.62 |
| ▸ | CA2 | P00918 | 3/20 | 0.62 |
| ▸ | CA4 | P22748 | 3/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA6 | P23280 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CA5A | P35218 | 1/20 | 0.62 |
| ▸ | CA7 | P43166 | 1/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.62 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.62 |
| ▸ | HTR6 | P50406 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KYNU | Q16719 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250199 | 0.81 | ALDH1A1 (0.55) | GAACA9CA1CA2CA4 | |
| SCHEMBL10585490 | 0.79 | GAA (1.00) | GAACA9CA1CA2CA4 | |
| SCHEMBL30223488 | 0.79 | GAA (1.00) | GAACA9CA1CA2CA4 | |
| SCHEMBL34423 | 0.79 | GAA (1.00) | GAACA9CA1CA2CA4 | |
| SCHEMBL28553999 | 0.78 | CYP3A4 (0.62) | GAACA9CA1CA2CA4 | |
| SCHEMBL10565795 | 0.78 | SMN1; SMN2 (0.45) | GAACA9CA1CA2CA4 | |
| SCHEMBL7484553 | 0.78 | CYP3A4 (0.52) | GAACA9CA1CA2CA4 | |
| SCHEMBL8516378 | 0.78 | TTR (0.66) | GAACA9CA1CA2CA4 | |
| Hydrochloric Acid SCHEMBL11745781 | 0.77 | GAA (0.95) | GAACA9CA1CA2CA4 | |
| SCHEMBL6003437 | 0.77 | GAA (0.95) | GAACA9CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021114460-A1 | METHOD FOR PRODUCING P-ACETAMIDOBENZENESULFONYL CHLORIDE BY MEANS OF DOUBLE-TEMPERATURE-ZONE TWO-STAGE METHOD BASED ON CONTINUOUS FLOW REACTION | 山东金德新材料有限公司 | 2021-06-17 | — | — | WO | claimed |
| CN-104961660-B | A kind of acid inner salt compound of amidine | 苏州大学张家港工业技术研究院 | 2017-06-13 | — | — | CN | claimed |
| CN-104945287-B | A kind of synthetic method of the acid inner salt compound of amidine | 苏州大学张家港工业技术研究院 | 2017-06-13 | — | — | CN | claimed |
| CN-104961660-A | Inner salt compound of amidine sulfonic acid | ZHANGJIAGANG INST IND TECHNOLOGIES SOOCHOW UNIV | 2015-10-07 | — | — | CN | claimed |
| CN-104945287-A | Synthetic method of sulfonic acid inner salt compound of amidine | ZHANGJIAGANG INST IND TECHNOLOGIES SOOCHOW UNIV | 2015-09-30 | — | — | CN | claimed |
| JP-51151293-A | — | — | None | — | — | JP | disclosed |
| CN-116536940-B | Affinity-convertible disperse reactive dye nonaqueous medium dyeing process | 东华大学 | 2025-05-23 | — | — | CN | disclosed |
| CN-119241399-A | Benzenesulfonyl compound taking AR/AR-V7 double protein as target point and preparation method and application thereof | 上海应用技术大学 | 2025-01-03 | — | — | CN | disclosed |
| CN-116536940-A | Affinity-convertible disperse reactive dye nonaqueous medium dyeing process | 东华大学 | 2023-08-04 | — | — | CN | disclosed |
| CN-109384694-B | SIRT6 small-molecule agonist and application thereof | 上海爱乐维生物科技有限公司 | 2022-04-05 | — | — | CN | disclosed |
| US-20200055830-A1 | 3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS | Valo Health, LLC | 2020-02-20 | — | — | US | disclosed |
| CN-109384694-A | SIRT6 small molecule agonist and its application | 上海交通大学医学院 | 2019-02-26 | — | — | CN | disclosed |
| US-4976891-A | Antithrombotic, antivasoconstricting, antibronchoconstricting | SHIONOGI & CO., LTD. (JP) | 1990-12-11 | — | — | US | disclosed |
| US-4960909-A | ANTICOAGULANTS; VASODILATORS; BRONCHODILATOR AGENTS | SHIONOGI & CO., LTD. (JP) | 1990-10-02 | — | — | US | disclosed |
| US-4861913-A | Bicyclic sulfonamide derivatives | SHIONOGI & CO., LTD. (JP) | 1989-08-29 | — | — | US | disclosed |
| US-4835312-A | Production process of N-substituted amide compounds | MITSUI CHEMICALS, INCORPORATED (JP) | 1989-05-30 | — | — | US | disclosed |
| EP-0262395-A2 | Sulfonamido-ethyl compounds, medicines containing them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1988-04-06 | — | — | EP | disclosed |
| EP-0226346-A1 | Bicyclic sulfonamide derivatives | SHIONOGI & CO., LTD. (JP) | 1987-06-24 | — | — | EP | disclosed |
| US-4558121-A | Sulfoethylaminosulfonyl substituted disazo dyes | CIBA GEIGY CORPORATION (US) | 1985-12-10 | — | — | US | disclosed |
| JP-S51151293-A | PROCESS FOR PURIFICATION AND RECOVERY OF THE SULFURIC ACID BY-PRODUCT | NISSAN CHEM IND LTD | 1976-12-25 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055830-A1 | 3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS | HDAC1, HDAC4, HDAC2 | GAA 89/4885CA9 1651/4885CA1 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.